Rx Analysts (Current / Former) How Did You Think About Exits?
Given that Rx Analysts at the top firms (PJT, HL, EVR, LAZ, MOE) have a plethora of options to choose from, how did you decide between MF/UMM Private Equity (Bx, Apollo, KKR, etc.), Credit (Oaktree, Centerbridge, etc.) Distressed HF's (Aurelius, Angelo Gordon, Silver Point, etc.), L/S Shops (Viking, Maverick, etc.), Special Situations (Apollo HV, Bx TacOps, Ares SpecOps)?
Would love to hear your rationale behind the decision as well and if you would've changed anything.
Currently an analyst at one of the banks mentioned above. I'm going to get a lot of MS for this but in RX you dont really get looks from MF's for their flagship funds ("normal PE"). Not saying there's no chance - but it is very difficult - you'll likely be steered towards their credit/ss arm. If you do RX make sure you really like credit/distressed and are not doing just because its "in" right now - it's a very tough space to be in when things are going really well from a macro perspective and the space is very crowded at the moment.